CELG.RT
Wells Fargo’s Bristol-Myers Squibb Company Contingent Value Rights CELG.RT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $0 | Hold |
28
| – | – | ﹤0.01% | 6674 |
|
|
2025
Q1 | $1 | Hold |
28
| – | – | ﹤0.01% | 6513 |
|
|
2024
Q4 | $1 | Hold |
28
| – | – | ﹤0.01% | 6501 |
|
|
2024
Q3 | $1 | Hold |
28
| – | – | ﹤0.01% | 6442 |
|
|
2024
Q2 | $1 | Hold |
28
| – | – | ﹤0.01% | 6430 |
|
|
2024
Q1 | $2 | Sell |
28
-3
| -10% | – | ﹤0.01% | 7052 |
|
|
2023
Q4 | $3 | Buy |
31
+3
| +11% | – | ﹤0.01% | 7074 |
|
|
2023
Q3 | $3 | Hold |
28
| – | – | ﹤0.01% | 7136 |
|
|
2023
Q2 | $3 | Buy |
28
+1
| +4% | – | ﹤0.01% | 7228 |
|
|
2023
Q1 | $3 | Sell |
27
-1
| -4% | – | ﹤0.01% | 7296 |
|
|
2022
Q4 | $3 | Hold |
28
| – | – | ﹤0.01% | 7088 |
|
|
2022
Q3 | $0 | Hold |
28
| – | – | ﹤0.01% | 6376 |
|
|
2022
Q2 | $0 | Buy |
28
+18
| +180% | – | ﹤0.01% | 6542 |
|
|
2022
Q1 | $0 | Hold |
10
| – | – | ﹤0.01% | 6696 |
|
|
2021
Q4 | $0 | Hold |
10
| – | – | ﹤0.01% | 6683 |
|
|
2021
Q3 | $0 | Sell |
10
-252
| -96% | – | ﹤0.01% | 6643 |
|
|
2021
Q2 | $0 | Hold |
262
| – | – | ﹤0.01% | 6566 |
|
|
2021
Q1 | $0 | Hold |
262
| – | – | ﹤0.01% | 6515 |
|
|
2020
Q4 | $0 | Hold |
262
| – | – | ﹤0.01% | 6145 |
|
|
2020
Q3 | $0 | Hold |
262
| – | – | ﹤0.01% | 5974 |
|
|
2020
Q2 | $0 | Hold |
262
| – | – | ﹤0.01% | 5905 |
|
|
2020
Q1 | $0 | Hold |
262
| – | – | ﹤0.01% | 5865 |
|
|
2019
Q4 | $0 | Buy |
+262
| New | – | ﹤0.01% | 5890 |
|